10바이알 팩재고 622% 할인CJC-1295 + Ipamorelin 5 mg + 5 mg
고전적 GHRH + 그렐린 모방 스택
CJC-1295 and Ipamorelin research stack, Australian-shipped. Lab-verified to ≥99% purity.
연구 전용. 이 화합물은 체외 연구 및 실험실 용도로만 판매되며, 인체 섭취나 치료 목적 사용을 의도하지 않습니다. 구매함으로써 귀하가 자격을 갖춘 연구자이며 당사의 전체 면책 조항에 동의하는 것으로 간주됩니다.
6팩만 남음
CJC-1295(GHRH 유사체)와 선택적 그렐린 모방제 Ipamorelin을 하나의 연구용 바이알에 조합한 제품. 펩타이드 연구에서 가장 많이 검토된 이중 기전 GH 분비촉진 스택입니다.
CJC-1295 and Ipamorelin are a long-standing pair in growth-hormone secretagogue research. CJC-1295 is a 30-amino-acid analogue of growth-hormone-releasing hormone (GHRH); Ipamorelin is a selective ghrelin receptor agonist (a 'GHS' or growth-hormone secretagogue). The two compounds act on different receptors but converge on the somatotrophs of the anterior pituitary, where they amplify pulsatile growth-hormone release in pre-clinical models.
Quantum Labs supplies the pair as a pre-portioned research stack — two lyophilised vials shipped together, each HPLC-verified to ≥99% purity. Australian-shipped from local stock; supplied for laboratory research use only.
작용 기전
CJC-1295는 기저 GHRH 수용체 신호를 지원하고, Ipamorelin은 선택적 그렐린 수용체 펄스를 구동합니다. 연구는 연구 대상에서 시너지적·생리적 GH 방출 패턴을 시사합니다.
순도 규격 ≥99%에 대해 HPLC로 검증되었습니다. 인증된 제3자 실험실에서 독립적으로 시험합니다.
CJC-1295: DAC vs no-DAC
CJC-1295 exists in two research forms: with Drug Affinity Complex (DAC) and without. The DAC variant binds albumin in plasma, extending the half-life from minutes to days. Research designs targeting acute pulsatile GH release typically use the no-DAC form (modified GRF 1-29); studies modelling sustained GH elevation use the DAC variant. Our supply is the no-DAC research-grade form unless otherwise specified.
CJC-1295 + Ipamorelin — 자주 묻는 질문
What is the CJC-1295 + Ipamorelin stack?
It is a research pairing of two growth-hormone secretagogues: CJC-1295 (a GHRH analogue) and Ipamorelin (a selective ghrelin receptor agonist). The two compounds act on different receptors but converge on stimulating pulsatile growth-hormone release in pre-clinical models.
How does CJC-1295 differ from Ipamorelin?
CJC-1295 mimics growth-hormone-releasing hormone (GHRH), binding the GHRH receptor on pituitary somatotrophs. Ipamorelin mimics ghrelin, binding the growth-hormone secretagogue receptor (GHSR-1a). The two pathways are independent but synergistic — combining them produces a larger pulsatile GH response in research models than either compound alone.
Is CJC-1295 + Ipamorelin legal in Australia?
Both compounds are restricted for human therapeutic supply in Australia and remain available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies the stack for research use only.
What does selective mean for Ipamorelin?
Ipamorelin is described as a selective ghrelin agonist because it activates the GH-release pathway with minimal effect on cortisol, prolactin, or aldosterone — distinguishing it from earlier-generation GHS molecules. This selectivity has made it a preferred research tool for isolating GH-specific effects.
What is the typical CJC-1295 + Ipamorelin research dosage?
Published research protocols have used wide dose ranges depending on the model and species. Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Are CJC-1295 and Ipamorelin used together?
Yes — combined-administration research is common precisely because the two compounds act on independent receptors and produce a synergistic GH-release response. The combination is a standard tool in growth-hormone secretagogue research.
CJC-1295 + Ipamorelin 관련 가이드
연구자들이 함께 살펴보는 항목
10바이알 팩18% 할인Tesamorelin
동결건조 분말10 mg · 3 strengths
안정화 GHRH 유사체
1개 스택에 포함
추천10바이알 팩22% 할인Melanotan II
동결건조 분말10 mg
α-MSH 유사체 연구 펩타이드